Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Diagnostics and Research

Waters Corporation provides high-performance liquid chromatography products and services. The Company distributes its products worldwide to a wide range of industries such as pharmaceuticals, chemicals, and environmental testing. Waters also designs, manufactures, sells, and services thermal analysis, rheometry, calorimetry instruments, and related software products.
Website: waters.com



Growth: Bad revenue growth rate -4.7%, there is slowdown compared to average historical growth rates 8.9%. The revenue growth dynamics is unstable Site traffic for the last 3 months showed a change of -8.7%

Profitability: LTM EBITDA margin is positive, +33.2%. On average the margin is improving unsteadily. Gross margin is high, +59.7%. In the last quarter the company did not beat the estimated EPS, -4.6%. The company was ahead of estimated EPS in 80% of quarters (showing a gain of +$0.13 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield -5.0% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 24.3% higher than minimum and 30.7% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.4x by EV / Sales multiple , the company can be 48.8% overvalued

Insiders: For the last 3 months insiders sold company shares on $0.2 mln (-0.001% of cap.)

Key Financials (Download financials)

Ticker: WAT
Share price, USD:  (-3.3%)294.23
year average price 291.46  


year start price 306.90 2023-04-21

min close price 236.70 2023-10-30

max close price 361.00 2024-03-07

current price 294.23 2024-04-19
Common stocks: 59 329 000

Dividend Yield:  0.0%
FCF Yield LTM: -5.0%
EV / LTM EBITDA: 19.8x
EV / EBITDA annualized: 15.6x
Last revenue growth (y/y):  -4.7%
Last growth of EBITDA (y/y):  -1.9%
Historical revenue growth:  8.9%
Historical growth of EBITDA:  13.7%
EV / Sales: 6.6x
Margin (EBITDA LTM / Revenue): 33.2%
Fundamental value created in LTM:
Market Cap ($m): 17 456
Net Debt ($m): 1 960
EV (Enterprise Value): 19 416
Price to Book: 15.7x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2024-04-11Zacks Investment Research

Waters (WAT) Boosts Waters Operating Segment With HPLC System

2024-03-18Zacks Investment Research

Waters (WAT) Boosts PFAS Testing Solutions With New Cartridges

2024-03-15Zacks Investment Research

Waters (WAT) Boosts Portfolio Strength With Rheo-IS Accessory

2024-03-07Zacks Investment Research

Why Is Waters (WAT) Up 7.9% Since Last Earnings Report?

2024-02-29Zacks Investment Research

Waters (WAT) Boosts LC Solutions Portfolio With New Software

2024-02-22PRNewsWire

Waters Corporation to Present at the TD Cowen 44th Annual Health Care Conference

2024-02-06Zacks Investment Research

Waters (WAT) Q4 Earnings & Sales Beat Estimates, Fall Y/Y

2024-02-06Seeking Alpha

Waters Corporation (WAT) Q4 2023 Earnings Call Transcript

2024-02-06Zacks Investment Research

Waters (WAT) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

2024-02-06Zacks Investment Research

Waters (WAT) Beats Q4 Earnings and Revenue Estimates
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-10-01
symbol WAT WAT WAT WAT WAT WAT
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-27 2023-11-07 2023-08-02 2023-05-09 2023-02-27 2022-11-03
acceptedDate 2024-02-27 11:52:37 2023-11-07 07:10:24 2023-08-02 07:04:58 2023-05-09 09:06:21 2023-02-27 16:32:19 2022-11-03 11:09:04
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
revenue 819M 712M 741M 685M 859M 709M
costOfRevenue 331M 291M 301M 284M 348M 307M
grossProfit 489M 420M 440M 400M 510M 401M
grossProfitRatio 0.597 0.591 0.593 0.585 0.594 0.567
researchAndDevelopmentExpenses 44M 42M 46M 43M 48M 43M
generalAndAdministrativeExpenses 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 179M 187M 187M 182M 174M 164M
otherExpenses -557 000 328 000 -352 000 1M 2M 2M
operatingExpenses 223M 241M 240M 226M 224M 209M
costAndExpenses 554M 532M 541M 511M 572M 517M
interestIncome 5M 4M 4M 4M 3M 3M
interestExpense 26M 27M 23M 10M 10M 10M
depreciationAndAmortization 48M 48M 39M 33M 31M 33M
ebitda 314M 228M 242M 207M 317M 225M
ebitdaratio 0.383 0.320 0.327 0.302 0.370 0.318
operatingIncome 266M 179M 200M 174M 286M 192M
operatingIncomeRatio 0.324 0.252 0.270 0.254 0.333 0.271
totalOtherIncomeExpensesNet -28M 328 000 -352 000 -9M -11M -9M
incomeBeforeTax 238M 153M 180M 165M 275M 183M
incomeBeforeTaxRatio 0.290 0.215 0.243 0.241 0.321 0.259
incomeTaxExpense 21M 19M 30M 24M 48M 27M
netIncome 216M 135M 151M 141M 227M 156M
netIncomeRatio 0.264 0.189 0.203 0.206 0.264 0.220
eps 3.660 2.280 2.560 2.390 3.830 2.610
epsdiluted 3.650 2.270 2.550 2.380 3.810 2.600
weightedAverageShsOut 59M 59M 59M 59M 59M 60M
weightedAverageShsOutDil 59M 59M 59M 59M 60M 60M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Balance Sheet Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-10-01
symbol WAT WAT WAT WAT WAT WAT
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-27 2023-11-07 2023-08-02 2023-05-09 2023-02-27 2022-11-03
acceptedDate 2024-02-27 11:52:37 2023-11-07 07:10:24 2023-08-02 07:04:58 2023-05-09 09:06:21 2023-02-27 16:32:19 2022-11-03 11:09:04
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
cashAndCashEquivalents 395M 336M 330M 486M 481M 444M
shortTermInvestments 898 000 898 000 885 000 885 000 862 000 876 000
cashAndShortTermInvestments 396M 337M 331M 487M 481M 445M
netReceivables 702M 631M 693M 683M 723M 601M
inventory 516M 544M 537M 499M 456M 442M
otherCurrentAssets 138M 122M 120M 104M 104M 88M
totalCurrentAssets 1 753M 1 513M 1 681M 1 670M 1 660M 1 488M
propertyPlantEquipmentNet 724M 617M 708M 590M 582M 547M
goodwill 1 305M 1 308M 1 314M 432M 430M 420M
intangibleAssets 629M 631M 650M 233M 227M 213M
goodwillAndIntangibleAssets 1 935M 1 939M 1 963M 664M 658M 634M
longTermInvestments 5M 129 000 0 0 0 0
taxAssets 0 -129 000 0 0 0 0
otherNonCurrentAssets 211M 428M 196M 383M 382M 401M
totalNonCurrentAssets 2 874M 2 984M 2 867M 1 637M 1 621M 1 582M
otherAssets 0 0 0 0 0 0
totalAssets 4 627M 4 497M 4 548M 3 307M 3 281M 3 070M
accountPayables 85M 80M 82M 94M 93M 97M
shortTermDebt 78M 77M 76M 1 480M 76M 74M
taxPayables 120M 113M 121M 151M 133M 117M
deferredRevenue 257M 276M 325M 307M 228M 249M
otherCurrentLiabilities 370M 313M 327M -400M 388M 312M
totalCurrentLiabilities 790M 745M 809M 1 480M 786M 732M
longTermDebt 2 306M 2 455M 2 647M 1 492M 1 575M 1 545M
deferredRevenueNonCurrent 67M 64M 0 0 0 0
deferredTaxLiabilitiesNonCurrent 59M 60M 0 0 0 0
otherNonCurrentLiabilities 255M 267M 321M -266M 1 202M 2 265M
totalNonCurrentLiabilities 2 687M 2 847M 2 968M 1 227M 2 777M 2 685M
otherLiabilities 0 0 0 0 -786M -732M
capitalLeaseObligations 59M 60M 93M 87M 89M 86M
totalLiabilities 3 477M 3 592M 3 777M 2 707M 2 777M 2 685M
preferredStock 0 0 0 0 0 0
commonStock 2M 2M 2M 2M 2M 2M
retainedEarnings 9 151M 8 935M 8 800M 8 650M 8 509M 8 282M
accumulatedOtherComprehensiveIncomeLoss -134M -146M -129M -133M -142M -164M
othertotalStockholdersEquity -7 868M -7 884M -7 902M -7 919M -7 864M -7 734M
totalStockholdersEquity 1 150M 906M 771M 600M 504M 385M
totalEquity 1 150M 906M 771M 600M 504M 385M
totalLiabilitiesAndStockholdersEquity 4 627M 4 497M 4 548M 3 307M 3 281M 3 070M
minorityInterest 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 4 627M 4 497M 4 548M 3 307M 3 281M 3 070M
totalInvestments 6M 1M 885 000 885 000 862 000 876 000
totalDebt 2 442M 2 592M 2 723M 1 480M 1 651M 1 545M
netDebt 2 047M 2 256M 2 393M 994M 1 171M 1 101M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Cash Flow Statement

Property 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3
date 2023-12-31 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-10-01
symbol WAT WAT WAT WAT WAT WAT
reportedCurrency USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M
fillingDate 2024-02-27 2023-11-07 2023-08-02 2023-05-09 2023-02-27 2022-11-03
acceptedDate 2024-02-27 11:52:37 2023-11-07 07:10:24 2023-08-02 07:04:58 2023-05-09 09:06:21 2023-02-27 16:32:19 2022-11-03 11:09:04
calendarYear 2023.000 2023.000 2023.000 2023.000 2022.000 2022.000
period Q4 Q3 Q2 Q1 Q4 Q3
netIncome 216M 135M 151M 141M 227M 156M
depreciationAndAmortization 48M 48M 39M 31M 31M 32M
deferredIncomeTax -1M 7M -1M -5M -11M -8M
stockBasedCompensation -61M 8M 11M 13M 12M 10M
changeInWorkingCapital -37M -39M -181M 12M -71M -40M
accountsReceivables -51M 50M 6M 44M -99M 18M
inventory 36M -18M -21M -43M 11M -48M
accountsPayables 51M -7M -52M -71M 66M 27M
otherWorkingCapital -73M -64M -115M 82M -50M -38M
otherNonCashItems 65M -651 000 0 5M 11M 8M
netCashProvidedByOperatingActivities 230M 158M 18M 197M 199M 158M
investmentsInPropertyPlantAndEquipment -42M -38M -47M -34M -62M -42M
acquisitionsNet 4M 651 000 -1 286M 0 0 0
purchasesOfInvestments 0 -898 000 0 -16 000 0 -448 000
salesMaturitiesOfInvestments 91 000 2M 0 877 000 -9M 4M
otherInvestingActivites 0 -651 000 0 -877 000 9M 0
netCashUsedForInvestingActivites -38M -37M -1 333M -34M -62M -38M
debtRepayment -150M -125M -250M -145M -10M 0
commonStockIssued 12M 9M 0 0 0 0
commonStockRepurchased 156 000 -692 000 -236 000 -70M -149M -155M
dividendsPaid 0 0 0 0 0 0
otherFinancingActivites 8M 3M 1 408M 55M 47M 67M
netCashUsedProvidedByFinancingActivities -130M -114M 1 158M -159M -111M -88M
effectOfForexChangesOnCash -3M -171 000 -155 000 2M 12M -7M
netChangeInCash 59M 7M -156M 6M 37M 25M
cashAtEndOfPeriod 395M 336M 330M 486M 481M 444M
cashAtBeginningOfPeriod 336M 330M 486M 481M 444M 419M
operatingCashFlow 230M 158M 18M 197M 199M 158M
capitalExpenditure -42M -38M -47M -34M -62M -42M
freeCashFlow 189M 120M -28M 162M 137M 116M
link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link

Earning call transcript

2023 q4
2024-02-06 ET (fiscal 2023 q4)
2023 q3
2023-11-07 ET (fiscal 2023 q3)
2023 q2
2023-08-02 ET (fiscal 2023 q2)
2023 q1
2023-05-09 ET (fiscal 2023 q1)
2022 q4
2023-02-15 ET (fiscal 2022 q4)
2022 q3
2022-11-01 ET (fiscal 2022 q3)
2022 q2
2022-08-02 ET (fiscal 2022 q2)
2022 q1
2022-05-03 ET (fiscal 2022 q1)

Press-releases

Show financial reports only

2024-02-06 11:50 ET
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2023 Financial Results
2024-01-18 14:00 ET
Waters Corporation Schedules Fourth Quarter 2023 Earnings Conference Call
2023-12-21 18:50 ET
Waters Corporation to Present at the 42nd Annual J.P. Morgan Healthcare Conference
2023-12-19 13:00 ET
Waters Earns Sustainability Designation from My Green Lab for Xevo TQ Absolute System
2023-12-19 12:30 ET
Waters Corporation Named to Dow Jones Sustainability Index for the Third Consecutive Year
2023-12-18 13:15 ET
Waters Corporation Board of Directors Named 2024 Public Company Board of the Year by National Association of Corporate Directors New England Chapter
2023-12-18 12:48 ET
NACD New England honors Waters Corp. and Devoted Health as Public and Private Company “Boards of the Year”
2023-12-06 11:30 ET
Waters Corporation Opens New State-of-the-Art Global Capability Center in Bengaluru, India
2023-12-05 13:30 ET
Waters Earns Top Score in Human Rights Campaign Foundation's 2023-2024 Corporate Equality Index
2023-11-16 18:06 ET
Waters Corporation to Present at the Evercore ISI HealthCONx 2023 Health Care Conference
2023-11-16 13:00 ET
WATERS 2023 ESG REPORT HIGHLIGHTS CONTINUED PROGRESS TOWARDS SUSTAINABILITY COMMITMENTS
2023-11-07 11:50 ET
Waters Corporation (NYSE: WAT) Reports Third Quarter 2023 Financial Results
2023-10-24 12:45 ET
Waters Corporation Announces Business Unit Leadership Transition
2023-10-19 12:00 ET
Waters Accelerates Oligonucleotide Bioanalysis with the Launch of OligoWorks™ SPE Workflow and Kits
2023-10-10 17:20 ET
Waters Corporation Schedules Third Quarter 2023 Earnings Conference Call
2023-09-20 12:00 ET
Waters ZetaStar Instrument Boosts Speed and Sensitivity of Light Scattering Measurements for Biological Therapies
2023-09-12 12:00 ET
Waters Launches New Walk-up Solutions that Further Simplify the Analysis of Biologic Drug Product and Cell Culture Media
2023-08-30 15:00 ET
Waters Corporation to Present at the Bank of America Global Healthcare Conference 2023
2023-08-02 10:50 ET
Waters Corporation (NYSE: WAT) Reports Second Quarter 2023 Financial Results
2023-08-01 19:45 ET
Waters Launches XBridge Premier GTx BEH SEC Columns for Gene Therapy Applications
2023-07-05 18:19 ET
Waters Corporation Schedules Second Quarter 2023 Earnings Conference Call
2023-06-26 12:00 ET
Waters Corporation and Princeton University Announce Multi-Year Research Collaboration
2023-06-12 15:00 ET
Waters Corporation Named to U.S. News & World Report's 2023-2024 Best Companies to Work For
2023-06-05 19:47 ET
Waters Boosts Resolution and Triples Scan Speed of SELECT SERIES MRT for Metabolomics and MS Imaging
2023-06-05 13:05 ET
Waters Takes Targeted, Quantitative Imaging to the Next Level with New DESI Source for the Xevo TQ Absolute System
2023-06-05 12:00 ET
Waters and Sartorius Expand Collaboration to Deliver Comprehensive Bioanalytics for Downstream Biomanufacturing
2023-05-23 17:11 ET
Waters Corporation to Present at the Jefferies 2023 Healthcare Conference
2023-05-16 20:15 ET
Waters Corporation Completes Acquisition of Light Scattering Leader Wyatt Technology
2023-05-09 10:50 ET
Waters Corporation (NYSE: WAT) Reports First Quarter 2023 Financial Results
2023-04-17 18:53 ET
Waters Corporation Schedules First Quarter 2023 Earnings Conference Call
2023-04-04 13:15 ET
Waters Launches its Most Sensitive and Compact Clinical IVD System with Xevo TQ Absolute IVD Mass Spectrometer
2023-03-28 12:00 ET
Waters Corporation Appoints Richard Fearon to Board of Directors
2023-03-20 12:00 ET
Waters Introduces Next-Generation Alliance iS HPLC System Aimed at Reducing Up to 40% of Common Lab Errors
2023-03-20 11:55 ET
Waters’ New Battery Cycler Microcalorimeter Solution Accelerates Real-World Testing from Months to Weeks
2023-03-15 13:00 ET
Waters Corporation Listed as No. 5 on Barron's 100 Most Sustainable Companies 2023 List
2023-02-23 15:19 ET
Waters Corporation Presentation at the Cowen 43rd Annual Health Care Conference to be Webcast Live
2023-02-15 11:50 ET
Waters Corporation (NYSE: WAT) Reports Fourth Quarter and Full-Year 2022 Financial Results
2023-02-15 11:45 ET
Waters Corporation to Acquire Wyatt Technology, Light Scattering Instrument and Software Leader
2023-01-25 13:00 ET
New waters_connect System Monitoring Software Maximizes Productivity with Real-Time, Cloud-Native Lab Management
2023-01-18 20:05 ET
Waters Corporation Schedules Fourth Quarter 2022 Earnings Conference Call
2023-01-05 14:00 ET
Waters Corporation Recognized for its Award-winning Products, Outstanding Leadership, and ESG Progress
2022-12-19 21:16 ET
Waters Corporation Presentation at the 41st Annual J.P. Morgan Healthcare Conference to Be Audio Webcast Live
2022-12-19 13:05 ET
Waters Corporation Named to Dow Jones Sustainability Index for Second Consecutive Year
2022-11-23 13:00 ET
Waters Corporation Appoints Dan Brennan and Mark Vergnano to Board of Directors
2022-11-22 13:00 ET
Waters Introduces New PFAS Quantitation Workflow Enabled by Enhancements to waters_connect Informatics Platform
2022-11-17 18:56 ET
Waters Corporation Presentation at the Evercore ISI HealthconX 2022 Virtual Health Care Conference to Be Webcast Live
2022-11-10 13:03 ET
Waters Highlights ESG Progress and New Commitments in its 2022 Report
2022-11-01 10:50 ET
Waters Corporation (NYSE: WAT) Reports Third Quarter 2022 Financial Results
2022-10-11 12:00 ET
Waters Automates Solid Phase Extraction of Biological, Food and Environmental Samples with Andrew+ Pipetting Robot
2022-10-07 08:00 ET
Waters Marks 25 Years in Ireland with €6 Million Clinical Diagnostics R&D Center Expansion in Wexford
2022-10-05 19:25 ET
Waters Corporation Schedules Third Quarter 2022 Earnings Conference Call
2022-09-29 15:00 ET
Waters Extends Capabilities of Flagship TA Instruments Rheometer for Efficient and Repeatable Powder Analysis
2022-09-26 17:49 ET
Waters Announces Bay State’s First LEED-Certified Chemical Manufacturing Facility
2022-09-08 19:33 ET
Waters Corporation Presentation at the Bank of America 2022 Global Health Care Conference
2022-08-02 10:50 ET
Waters Corporation (NYSE: WAT) Reports Second Quarter 2022 Financial Results
2022-07-26 12:00 ET
Waters Collaborates with Leading Researchers and Industry Partners to Advance the Science of Alternative Proteins
2022-07-11 14:33 ET
Waters Corporation Schedules Second Quarter 2022 Earnings Conference Call
2022-06-20 23:00 ET
Waters and BioInfra Establish the ASEAN Academy for Bioanalysis to Promote Analytical Skills Development
2022-06-06 12:00 ET
Waters Introduces High Resolution Mass Spectrometry Products and Software to Accelerate Drug Development
2022-05-26 19:11 ET
Waters Corporation Presentation at the Jefferies 2022 Global Health Care Conference
2022-05-05 12:12 ET
Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab
2022-05-03 10:50 ET
Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results
2022-04-19 20:40 ET
Waters Corporation to Host Investor Day
2022-04-07 14:49 ET
Waters Corporation Q1 2022 Financial Results Webcast Invitation
2022-03-31 12:00 ET
Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer
2022-03-22 12:00 ET
Waters Introduces Faster, Reliable and Automated Solution for Mass and Purity Analysis of Biomolecules
2022-02-25 20:00 ET
Waters Corporation Presentation at the Cowen 42nd Annual Health Care Conference
2022-02-15 16:04 ET
Waters Corporation Virtual Fireside Chat at Citi’s 2022 Virtual Healthcare Conference (including: Services, MedTech, Life Science Tools & HCIT)
2022-02-01 12:05 ET
Waters Acquires Charge Detection Mass Spectrometry Technology to Broaden its Application in Cell and Gene Therapy

SEC forms

Show financial reports only

SEC form 10
2024-02-27 00:00 ET
Waters published news for 2023 q4
SEC form 8
2024-02-06 00:00 ET
Waters published news for 2023 q4
SEC form 8
2024-02-06 00:00 ET
Waters reported for 2023 q4
SEC form 10
2023-11-07 07:10 ET
Waters published news for 2023 q3
SEC form 8
2023-11-07 06:59 ET
Waters reported for 2023 q3
SEC form 10
2023-11-07 00:00 ET
Waters published news for 2023 q3
SEC form 10
2023-08-02 07:04 ET
Waters reported for 2023 q2
SEC form 6
2023-08-02 07:00 ET
Waters published news for 2023 q2
SEC form 10
2023-08-02 00:00 ET
Waters published news for 2023 q2
SEC form 8
2023-08-02 00:00 ET
Waters published news for 2023 q2
SEC form 6
2023-06-21 17:08 ET
Waters published news for 2023 q1
SEC form 10
2023-05-09 00:00 ET
Waters published news for 2023 q1
SEC form 8
2023-05-09 00:00 ET
Waters published news for 2023 q1
SEC form 6
2023-03-28 08:16 ET
Waters published news for 2022 q4
SEC form 6
2023-03-07 07:30 ET
Waters published news for 2022 q4
SEC form 10
2023-02-27 16:32 ET
Waters reported for 2022 q4
SEC form 10
2023-02-27 00:00 ET
Waters reported for 2022 q4
SEC form 6
2023-02-15 07:16 ET
Waters published news for 2022 q4
SEC form 6
2023-01-09 17:25 ET
Waters published news for 2022 q4
SEC form 6
2022-12-14 09:42 ET
Waters published news for 2022 q3
SEC form 6
2022-11-23 08:00 ET
Waters published news for 2022 q3
SEC form 10
2022-11-03 11:09 ET
Waters reported for 2022 q3
SEC form 10
2022-11-03 00:00 ET
Waters reported for 2022 q3
SEC form 6
2022-11-01 07:00 ET
Waters published news for 2022 q3
SEC form 8
2022-11-01 00:00 ET
Waters reported for 2022 q3
SEC form 10
2022-08-04 16:44 ET
Waters reported for 2022 q2
SEC form 10
2022-08-04 00:00 ET
Waters reported for 2022 q2
SEC form 6
2022-08-02 07:00 ET
Waters published news for 2022 q2
SEC form 8
2022-08-02 00:00 ET
Waters reported for 2022 q2
SEC form 6
2022-06-22 17:16 ET
Waters published news for 2022 q1
SEC form 6
2022-05-25 17:04 ET
Waters published news for 2022 q1
SEC form 6
2022-05-19 08:31 ET
Waters published news for 2022 q1
SEC form 10
2022-05-05 09:36 ET
Waters reported for 2022 q1
SEC form 10
2022-05-05 00:00 ET
Waters reported for 2022 q1
SEC form 6
2022-05-03 07:00 ET
Waters published news for 2022 q1
SEC form 8
2022-05-03 00:00 ET
Waters reported for 2022 q1
SEC form 6
2022-04-14 08:00 ET
Waters published news for 2022 q1
SEC form 6
2022-04-01 10:00 ET
Waters published news for 2022 q1
SEC form 10
2022-02-24 13:04 ET
Waters published news for 2021 q4
SEC form 10
2022-02-24 00:00 ET
Waters published news for 2021 q4
SEC form 6
2022-02-01 07:01 ET
Waters published news for 2021 q4
SEC form 8
2022-02-01 00:00 ET
Waters published news for 2021 q4
SEC form 6
2022-01-10 07:31 ET
Waters published news for 2021 q4
SEC form 10
2021-11-04 10:35 ET
Waters published news for 2021 q3
SEC form 10
2021-11-04 00:00 ET
Waters published news for 2021 q3
SEC form 6
2021-11-02 07:00 ET
Waters published news for 2021 q3
SEC form 8
2021-11-02 00:00 ET
Waters published news for 2021 q3
SEC form 6
2021-10-06 07:30 ET
Waters published news for 2021 q3
SEC form 6
2021-09-20 15:19 ET
Waters published news for 2021 q2
SEC form 10
2021-08-05 09:22 ET
Waters published news for 2021 q2
SEC form 10
2021-08-05 00:00 ET
Waters published news for 2021 q2
SEC form 6
2021-08-03 07:01 ET
Waters published news for 2021 q2
SEC form 8
2021-08-03 00:00 ET
Waters published news for 2021 q2
SEC form 6
2021-06-24 07:31 ET
Waters published news for 2021 q1
SEC form 6
2021-06-22 16:47 ET
Waters published news for 2021 q1
SEC form 6
2021-05-12 13:17 ET
Waters published news for 2021 q1
SEC form 10
2021-05-06 10:49 ET
Waters published news for 2021 q1
SEC form 10
2021-05-06 00:00 ET
Waters published news for 2021 q1
SEC form 6
2021-05-05 07:00 ET
Waters published news for 2021 q1
SEC form 8
2021-05-05 00:00 ET
Waters published news for 2021 q1
SEC form 6
2021-04-21 07:30 ET
Waters published news for 2021 q1
SEC form 6
2021-04-01 08:00 ET
Waters published news for 2021 q1
SEC form 6
2021-03-04 07:30 ET
Waters published news for 2020 q4
SEC form 10
2021-02-24 14:57 ET
Waters published news for 2020 q4
SEC form 6
2021-02-02 06:50 ET
Waters published news for 2020 q4
SEC form 6
2021-01-12 06:52 ET
Waters published news for 2020 q4
SEC form 6
2020-12-15 09:01 ET
Waters published news for 2020 q3
SEC form 6
2020-12-10 08:56 ET
Waters published news for 2020 q3
SEC form 6
2020-12-03 07:09 ET
Waters published news for 2020 q3
SEC form 10
2020-10-28 10:07 ET
Waters published news for 2020 q3
SEC form 6
2020-10-27 06:50 ET
Waters published news for 2020 q3
SEC form 6
2020-10-08 16:48 ET
Waters published news for 2020 q3